2,523
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Centella asiatica enhances hepatic antioxidant status and regulates hepatic inflammatory cytokines in type 2 diabetic rats

, , &
Pages 1671-1678 | Received 08 Aug 2016, Accepted 08 Apr 2017, Published online: 27 Apr 2017

References

  • Agrawal NK, Kant S. 2014. Targeting inflammation in diabetes: newer therapeutic options. World J Diabetes. 5:697–710.
  • Akash MS, Rehman K, Chen S. 2013. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 114:525–531.
  • Ayepola OR, Cerf ME, Brooks NL, Oguntibeju OO. 2014. Kolaviron, a biflavonoid complex of Garcinia kola seeds modulates apoptosis by suppressing oxidative stress and inflammation in diabetes-induced nephrotoxic rats. Phytomedicine. 21:1785–1793.
  • Ayepola OR, Chegou NN, Brooks NL, Oguntibeju OO. 2013. Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses. BMC Complement Altern Med. 13:363.
  • Benzie IFF, Strain JJ. 1996. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 239:70–76.
  • Boada CAC, Martinez-Moreno JM. 2013. Pathophysiology of diabetes mellitus type 2: beyond the duo “insulin resistance-secretion deficit”. Nutr Hosp. 28:78–87.
  • Cavaillon JM. 2001. Pro- versus anti-inflammatory cytokines: myth or reality. Cell Mol Biol (Noisy-Le-Grand). 47:695–702.
  • Cruz NG, Sousa LP, Sousa MO, Pietrani NT, Fernandes AP, Gomes KB. 2013. The linkage between inflammation and type 2 diabetes mellitus. Diabetes Res Clin Pract. 99:85–92.
  • de Vries MA, Alipour A, Klop B, van de Geijn GJ, Janssen HW, Njo TL, van der Meulen N, Rietveld AP, Liem AH, Westerman EM, et al. 2015. Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls. Metab Clin Exp. 64:213–217.
  • Duran-Salgado MB, Rubio-Guerra AF. 2014. Diabetic nephropathy and inflammation. World J Diabetes. 5:393–398.
  • Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. 2014. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 105:141–150.
  • Farombi EO, Adedara IA, Oyenihi AB, Ekakitie E, Kehinde S. 2013. Hepatic, testicular and spermatozoa antioxidant status in rats chronically treated with Garcinia kola seed. J Ethnopharmacol. 146:536–542.
  • Fonseca VA. 2009. Defining and characterizing the progression of type 2 diabetes. Diabetes Care. 32:S151–S156.
  • Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Diabetes. 18:499–502.
  • Gadi R, Samaha FF. 2007. Dyslipidemia in type 2 diabetes mellitus. Curr Diab Rep. 7:228–234.
  • Galley H, Webster N. 1996. The immuno-inflammatory cascade. Br J Anaesth. 77:11–16.
  • Gohil KJ, Patel JA, Gajjar AK. 2010. Pharmacological review on Centella asiatica: a potential herbal cure-all. Indian J Pharm Sci 72:546–556.
  • Gornall AG, Bardawill CJ, David MM. 1949. Determination of serum proteins by means of the Biuret reaction. J Biol Chem 177:751–766.
  • Guo R, Liu B, Wang K, Zhou S, Li W, Xu Y. 2014. Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway. Diab Vasc Dis Res. 11:92–102.
  • Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 249:7130–7139.
  • Hamadi N, Mansour A, Hassan MH, Khalifi-Touhami F, Badary O. 2012. Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol. 26:384–392.
  • Jollow DJ, Mitchell JR, Zampagli N, Gillette JR. 1974. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 11:151–169.
  • Jornayvaz FR, Samuel VT, Shulman GI. 2010. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr. 30:273–290.
  • Kabir AUI, Bin Samad M, D'Costa NM, Akhter F, Ahmed A, Hannan JMA. 2014. Anti-hyperglycemic activity of Centella asiatica is partly mediated by carbohydrase inhibition and glucose-fiber binding. BMC Complement Altern Med. 14:34.
  • Katalinic V, Modun D, Music I, Boban M. 2005. Gender differences in antioxidant capacity of rat tissues determined by 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Physiol C Toxicol Pharmacol. 140:47–52.
  • Li YG, Ji DF, Zhong S, Lv ZQ, Lin TB, Chen S, Hu GY. 2011. Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabetic mice. J Ethnopharmacol. 134:961–970.
  • Ma Y, Wang Y, Huang Q, Ren Q, Chen S, Zhang A, Zhao L, Zhen Q, Peng Y. 2014. Impaired β cell function in Chinese newly diagnosed type 2 diabetes mellitus with hyperlipidemia. J Diabetes Res. 2014:493039.
  • Maduka IC, Onyeanusi JO, Shu EN, Duru C. 2007. Lipid and lipoprotein profiles in Nigerian non-insulin dependent diabetic patients. Biomed Res. 18:49–53.
  • Mahamuni SP, Khose RD, Menaa F, Badole SL. 2012. Therapeutic approaches to drug targets in hyperlipidemia. BioMedicine. 2:137–146.
  • Miller NJ, Riceevans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 84:407–412.
  • Mohammed A, Koorbanally NA, Islam MS. 2016. Anti-diabetic effect of Xylopia aethiopica (Dunal) A. Rich. (Annonaceae) fruit acetone fraction in a type 2 diabetes model of rats. J Ethnopharmacol. 180:131–139.
  • Moller DE. 2001. New drug targets for type 2 diabetes and the metabolic syndrome. Nature. 414:821–827.
  • Mutua PM, Gicheru MM, Makanya AN, Kiama SG. 2013. Anti-proliferative activities of Centella asiatica extracts on human respiratory epithelial cells in vitro. Int J Morphol. 31:1322–1327.
  • Norrapoke T, Wanapat M, Wanapat S, Foiklang S. 2014. Effect of Centella asiatica powder (Cap) and mangosteen peel powder (Mpp) on rumen fermentation and microbial population in swamp buffaloes. J Anim Plant Sci. 24:435–444.
  • Opal SM, DePalo VA. 2000. Anti-inflammatory cytokines. Chest J. 117:1162–1172.
  • Ou BX, Hampsch-Woodill M, Prior RL. 2001. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem. 49:4619–4626.
  • Oyenihi AB, Ayeleso AO, Mukwevho E, Masola B. 2015. Antioxidant strategies in the management of diabetic neuropathy. BioMed Res Int. 2015:515042.
  • Peerapatdit T, Sriratanasathavorn C. 2010. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai. 93:682–693.
  • Rains JL, Jain SK. 2011. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 50:567–575.
  • Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. 1973. Selenium: biochemical role as a component of glutathione peroxidase. Science. 179:588–590.
  • Siddique YH, Naz F, Jyoti S, Fatima A, Khanam S, Rahul Ali F, Mujtaba SF, Faisal M. 2014. Effect of Centella asiatica leaf extract on the dietary supplementation in transgenic Drosophila model of Parkinson's disease. Parkinsons Dis. 2014:262058.
  • Soumya D, Srilatha B. 2012. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011:1.
  • Taskinen MR, Boren J. 2015. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 239:483–495.
  • Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84.
  • Van Linthout S, Spillmann F, Schultheiss HP, Tschope C. 2010. High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. Curr Pharm Des. 16:1504–1516.
  • Varshney R, Kale RK. 1990. Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes. Int J Radiat Biol. 58:733–743.
  • Vinagre I, Sanchez-Quesada JL, Sanchez-Hernandez J, Santos D, Ordonez-Llanos J, De Leiva A, Perez A. 2014. Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of LDL subfraction phenotype. Cardiovasc Diabetol. 13:34.
  • Wilson RD, Islam MS. 2012. Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. Pharmacol Rep. 64:129–139.